84-1088-12 PRAS40, phosphorylated (Thr246) (Proline-Rich AKT Substrate 40kD Lobe, AKT151) 100ul P5640-15A

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • The proline-rich Akt substrate of 40 kilodaltons (PRAS40) was identified as a raptor binding protein that is phosphorylated directly by mTOR complex (mTORC) 1 but not mTORC 2 in vitro, predominantly at PRAS40 (Ser183).
  • The binding of S6K1 and 4E-BP1 to raptor requires a “TOR signaling” (TOS) motif which contains an essential Phe followed by four alternating acidic and small hydrophobic amino acids; PRAS40 binding to raptor was severely inhibited by mutation of PRAS40 (Phe129) to Ala; immediately carboxy-terminal to Phe129 are two small hydrophobic amino acid followed by two acidic residues, an arrangement different from that of the canonical TOS motif.
  • PRAS40 binding to raptor was also abolished by mutation of the major mTORC1 phosphorylation site Ser183, to Asp.
  • PRAS40 (Ser183) was phosphorylated in intact cells; as with S6K1 and 4E-BP1, PRAS40 (Ser183) phosphorylation was inhibited by rapamycin, by 2-deoxyglucose and by overexpression of the tuberous sclerosis complex heterodimer.
  • PRAS40 (Ser183) phosphorylation was also inhibited reversibly by withdrawal of all or of only the branched-chain amino acids; this inhibition was reversed by overexpression of the Rheb GTPase.
  • Overexpressed PRAS40 suppressed the phosphorylation of S6K1 and 4E-BP1 at their rapamycin-sensitive phosphorylation sites, and reciprocally, overexpression of S6K1 or 4E-BP1 suppressed phosphorylation of PRAS40 (Ser183) and its binding to raptor.
  • More importantly, RNAi-induced depletion of PRAS40 enhanced the amino-acid stimulated phosphorylation of both S6K1 and 4E-BP1.
  • These results establish PRAS40 as a physiological mTORC1 substrate that contains a variant TOS motif.
  • Moreover, they indicate that the capacity or ability of raptor to bind endogenous substrates is limiting for the activity of mTORC1 in vivo, and is therefore a potential locus of regulation, as suggested by others.
  • Applications:Suitable for use in Western Blot.
  • Other applications not tested.
  • Recommended Dilution:Western Blot: 1:1000 detected phosphorylated PRAS40 (Thr246) in RIPA lysates of unstimulated and PDGF stimulated NIH3T3 cells
  • Optimal dilutions to be determined by the researcher.
  • Positive Control:PDGF stimulated NIH3T3 cells.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Aliquots are stable for 12 months after receipt.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by affinity chromatography.
  • Form:Supplied as a liquid in PBS (without Mg2+ and Ca2+), pH 7.3, 1mg/ml BSA (IgG, protease free), 0.05% sodium azide, 50% glycerol.
  • Specificity:Recognizes phosphorylated human PRAS40 (Thr246). Species Crossreactivity: mouse
  • Isotype:IgG
  • Calc Applications Abbrev:WB
  • Calc Crossreactivity:Hu Mo
  • Immunogen:Peptide corresponding to amino acid region encompassing the human phospho-PRAS40 (Thr246).
  • Shelf Life:1year
  • Swiss Prot Number:Q96B36
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-1088-12
型番
P5640-15A
入り数
1個
標準価格
248,000円(税抜)
WEB価格
-円
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:点

お買い物を続ける カートを見る